Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Korean firm bids CHF1.5bn for Swiss pharma supplier Polypeptide
The company is offering CHF44.31 per share in cash, valuing Polypeptide at around CHF1.5 billion. Polypeptide's board of directors supports the offer, both companies announced on Monday. The major shareholder, Draupnir Holding, which holds just…
Chemists demand fair competition in pharma market amid online sales concerns
The All India Organisation of Chemists and Druggists (AIOCD) on Sunday (July 19, 2026) demanded that the government ensure an equitable ecosystem for all the players to sustain in the market by ensuring a level playing field. At its sixth…
Stocks to watch: JSW Steel, Alembic Pharma, Cipla, Laser Power, 5Paisa, Prestige Estates, NBCC (India)
The board of JSW Steel Ltd has approved the company's participation in the proposed IPO of JSW One Platforms Ltd (JOPL) as a promoter selling shareholder. The company plans to sell equity shares worth up to ₹811 crore through an offer for…
NervGen Pharma (NASDAQ:NGEN) Upgraded by Wall Street Zen to 'Hold' Rating
NervGen Pharma (NASDAQ:NGEN - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a 'sell' rating to a 'hold' rating in a research note issued on Monday. A number of other brokerages have also recently weighed in on NGEN.
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Receives Average Rating of 'Hold' from Brokerages
Shares of OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) have been assigned an average recommendation of 'Hold' from the five ratings firms that are presently covering the company, MarketBeat Ratings reports. One research analyst…
Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at $1.4 bn
Alembic Pharmaceuticals said its partner NATCO Pharma has received tentative approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Olaparib Tablets in 100 mg and 150 mg strengths, a…
The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Thursday's announcement that Eli Lilly will acquire AtaiBeckley, a clinical-stage maker of psychedelic drugs, for up to $3.8 billion indicates Big Pharma's increasing embrace of a long-stigmatized class of medications as alternatives for treating…
10 Companies Enter Rs 1 Trillion Club, 6 Exit
The number of companies with a market capitalisation of Rs 1 trillion or more rose to 114 in 2026, from 110 in the previous year. Ten companies entered the Rs 1 trillion club, while six exited it during the year. Companies that entered the club in…
Fake medicine manufacturing unit busted in Uttarakhand, 1 held
The Uttarakhand police's Special Task Force (STF) busted a gang involved in the manufacturing spurious allopathic medicines without a valid license, police said on Sunday. In a joint operation with the Drug Administration Department, the STF raided…
Teva stock's downward trend continues
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA ; TASE: TEVA) ended the trading week on Wall Street down 2.8% with falls on four of the five sessions last week. In fact, except for two trading days in early July and one trading day last week, the…
Sensex, Nifty open lower as banking stocks drag; crude spike rattles market
Benchmark indices opened in the red on Monday morning, dragged down by sharp selling in heavyweight banking stocks even as pharma and IT counters provided some support. The BSE Sensex, which closed at 78,151.45 on Friday, opened flat at 78,151.45…
Is It Too Late to Buy Johnson & Johnson After Its Blowout Earnings Report?
Johnson & Johnson (JNJ +1.22%) has been a top-performing stock this year. Investors, in many cases rotating out of riskier assets, have looked for companies with a strong track record of earnings growth, solid competitive positions, and a revenue…
FY2027 Earnings Estimate for LLY Issued By Erste Group Bank
As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner Eli Lilly and Company (NYSE:LLY - Free Report) - Equities researchers at Erste Group Bank increased their FY2027 earnings per share (EPS) estimates for shares of Eli Lilly and…
How drug companies are playing hardball with Australia's PBS
Australia is coming under increasing pressure from international drug companies demanding higher prices for their drugs. In some cases, negotiations have broken down and companies have said they'll withdraw their drugs from the market. In other…
Promising Growth Stocks Worth Watching - July 19th
Prologis Q1 2026: Data Centers Steal the Show Prologis, Teledyne Technologies, Ascendis Pharma A/S, Pattern Group, Hamilton Lane, Acadia Realty Trust, and Andersen Group are the seven Growth stocks to watch today, according to MarketBeat's stock…
Receive a Daily briefing on Pharma Industry News
Get Started